vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与TXO Partners, L.P.（TXO）财务数据对比。点击上方公司名可切换其他公司
TXO Partners, L.P.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$103.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 14.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 23.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
TXO Partners L.P.是一家总部位于美国的能源类业主有限合伙企业，专注于收购、开发及运营北美核心产油产气区的油气资产，业务覆盖上游勘探开采、中游能源运输，服务工业、公用事业及能源批发客户。
PBYI vs TXO — 直观对比
营收规模更大
TXO
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出13.3%
14.5%
两年增速更快
PBYI
近两年复合增速
23.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $103.7M |
| 净利润 | — | $-28.3M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | -26.1% |
| 净利率 | — | -27.2% |
| 营收同比 | 27.7% | 14.5% |
| 净利润同比 | — | -376.5% |
| 每股收益（稀释后） | $0.26 | $-0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITXO
| Q4 25 | $75.5M | $103.7M | ||
| Q3 25 | $54.5M | $90.6M | ||
| Q2 25 | $52.4M | $75.0M | ||
| Q1 25 | $46.0M | $93.8M | ||
| Q4 24 | $59.1M | $90.6M | ||
| Q3 24 | $80.5M | $69.3M | ||
| Q2 24 | $47.1M | $57.0M | ||
| Q1 24 | $43.8M | $68.5M |
净利润PBYITXO
| Q4 25 | — | $-28.3M | ||
| Q3 25 | $8.8M | $4.4M | ||
| Q2 25 | $5.9M | $-135.0K | ||
| Q1 25 | $3.0M | $2.4M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $20.3M | $203.0K | ||
| Q2 24 | $-4.5M | $2.8M | ||
| Q1 24 | $-4.8M | $10.3M |
毛利率PBYITXO
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYITXO
| Q4 25 | 22.7% | -26.1% | ||
| Q3 25 | 17.6% | 4.2% | ||
| Q2 25 | 12.7% | -5.0% | ||
| Q1 25 | 8.7% | -3.8% | ||
| Q4 24 | 22.6% | 6.1% | ||
| Q3 24 | 27.4% | -7.2% | ||
| Q2 24 | -4.6% | -17.7% | ||
| Q1 24 | -5.3% | 3.9% |
净利率PBYITXO
| Q4 25 | — | -27.2% | ||
| Q3 25 | 16.2% | 4.8% | ||
| Q2 25 | 11.2% | -0.2% | ||
| Q1 25 | 6.5% | 2.6% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | 25.2% | 0.3% | ||
| Q2 24 | -9.6% | 4.9% | ||
| Q1 24 | -11.0% | 15.0% |
每股收益（稀释后）PBYITXO
| Q4 25 | $0.26 | $-0.57 | ||
| Q3 25 | $0.17 | $0.08 | ||
| Q2 25 | $0.12 | $0.00 | ||
| Q1 25 | $0.06 | $0.06 | ||
| Q4 24 | $0.40 | $0.22 | ||
| Q3 24 | $0.41 | $0.01 | ||
| Q2 24 | $-0.09 | $0.09 | ||
| Q1 24 | $-0.10 | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $9.4M |
| 总债务越低越好 | $22.7M | $291.1M |
| 股东权益账面价值 | $130.3M | — |
| 总资产 | $216.3M | $1.4B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITXO
| Q4 25 | $97.5M | $9.4M | ||
| Q3 25 | $94.4M | $5.3M | ||
| Q2 25 | $96.0M | $8.0M | ||
| Q1 25 | $93.2M | $10.8M | ||
| Q4 24 | $101.0M | $7.3M | ||
| Q3 24 | $96.7M | $3.8M | ||
| Q2 24 | $96.8M | $76.0M | ||
| Q1 24 | $107.2M | $4.6M |
总债务PBYITXO
| Q4 25 | $22.7M | $291.1M | ||
| Q3 25 | $34.0M | $271.1M | ||
| Q2 25 | $45.3M | $19.1M | ||
| Q1 25 | $56.7M | $162.1M | ||
| Q4 24 | $68.0M | $157.1M | ||
| Q3 24 | $79.3M | $155.1M | ||
| Q2 24 | $90.7M | $7.1M | ||
| Q1 24 | $102.0M | $26.1M |
股东权益PBYITXO
| Q4 25 | $130.3M | — | ||
| Q3 25 | $115.3M | — | ||
| Q2 25 | $104.7M | — | ||
| Q1 25 | $97.1M | — | ||
| Q4 24 | $92.1M | — | ||
| Q3 24 | $71.1M | — | ||
| Q2 24 | $48.5M | — | ||
| Q1 24 | $51.0M | — |
总资产PBYITXO
| Q4 25 | $216.3M | $1.4B | ||
| Q3 25 | $202.9M | $1.4B | ||
| Q2 25 | $194.9M | $1.0B | ||
| Q1 25 | $196.2M | $1.0B | ||
| Q4 24 | $213.3M | $1.0B | ||
| Q3 24 | $220.7M | $1.0B | ||
| Q2 24 | $205.0M | $774.5M | ||
| Q1 24 | $214.1M | $688.2M |
负债/权益比PBYITXO
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $32.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYITXO
| Q4 25 | $14.4M | $32.5M | ||
| Q3 25 | $9.7M | $28.3M | ||
| Q2 25 | $14.1M | $26.9M | ||
| Q1 25 | $3.6M | $30.6M | ||
| Q4 24 | $15.6M | $40.5M | ||
| Q3 24 | $11.0M | $20.7M | ||
| Q2 24 | $1.0M | $22.9M | ||
| Q1 24 | $11.2M | $25.2M |
自由现金流PBYITXO
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYITXO
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYITXO
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYITXO
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 6.50× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | 12.67× | ||
| Q4 24 | — | 3.96× | ||
| Q3 24 | 0.54× | 102.02× | ||
| Q2 24 | — | 8.15× | ||
| Q1 24 | — | 2.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TXO
| Oil And Condensate | $92.8M | 89% |
| Natural Gas Liquids Reserves | $8.2M | 8% |
| Other | $2.8M | 3% |
